Biolargo, Inc.
BLGOCIK 0000880242 · last filing Jul 7, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
1,452,050 bought / 0 sold
net +1,452,050 sh · +$164.7K
- buys
- 3
- sells
- 0
- insiders active
- 2
Filing tape
Filed Tue, Jul 7, 2026
- +532,567 sh · $60.4K
Code Kenneth Reay — Chief Science Officer · Director
- Granted532,567Common Stock@ $0.11→ 26.4M held
Filed Thu, Jul 2, 2026
- +919,483 sh · $104.3K
Calvert Dennis P — President · Director
- Granted699,569Common Stock@ $0.11→ 10.8M held
- Granted219,914Common Stock@ $0.11→ 11.1M held
- ±0
Strommen Jack B. — Director
- Granted132,159Option to Purchase Common Stock→ 2,584,262 held
- ±0
Park Linda — Director
- Granted165,198Option to Purchase Common Stock→ 1,546,700 held
- ±0
Bray Christina Elaine — Director
- Granted165,198Option to Purchase Common Stock→ 1,546,700 held
- ±0
Marshall Dennis E — Director
- Granted198,238Option to Purchase Common Stock→ 5,639,476 held
- Granted115,741Option to Purchase Common Stock→ 5,804,674 held
Insiders on this tape
- Code Kenneth ReayChief Science Officer · Director
- Calvert Dennis PPresident · Director
- Strommen Jack B.Director
- Park LindaDirector
- Bray Christina ElaineDirector
- Marshall Dennis EDirector
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.